Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Filings indexed 590 across all filing types
Latest filing 2020-01-13 Major Shareholding Noti…
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to report changes in share ownership by major shareholders or insiders, which corresponds to the 'Major Shareholding Notification' category in the provided schema.
2020-01-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically by '푸른1호조합' in '루미마이크로(주)') due to stock sales and convertible bond adjustments. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-01-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. This type of filing is required when an entity's shareholding in a listed company crosses specific thresholds (typically 5%). It details the reporting entity (Dec 1st Fund), the issuer (Lumi Micro Co., Ltd.), and the specific changes in share ownership due to market sales, convertible bond adjustments, and fund distributions. This falls under the category of Major Shareholding Notification.
2020-01-10 Korean
신주인수권행사가액의조정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from a Korean company (Lumimicro) regarding the adjustment of the exercise price of warrants (신주인수권행사가액의조정). This type of disclosure is a standard corporate action related to capital structure and financing instruments, specifically detailing the recalculation of conversion/exercise prices due to corporate events like capital increases. It fits the 'Capital/Financing Update' category as it pertains to the terms of outstanding financial instruments.
2020-01-08 Korean
전환청구권행사(제7회차, 제8회차)
Capital/Financing Update Classification · 95% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (전환사채) into shares. This involves a change in the company's capital structure as debt is converted into equity. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2020-01-06 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for Lumimicro Co., Ltd. It details the meeting agenda, including proposed amendments to the articles of incorporation, election of directors, and election of auditors. It also includes background information on candidates and governance details. This type of document is a formal proxy statement/information circular provided to shareholders to solicit votes for an upcoming meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-01-03 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.